Leerink Partners Raises ISRG Price Target to $503
Key Points
- Leerink Partners maintained its Outperform rating on Intuitive Surgical, Inc. on October 21, 2026, lifting its target price from $473.00 to $503.00.
- Leerink Partners's $503 price target implies 17.51% upside from Intuitive Surgical, Inc.'s ($ISRG) current $428.05 share price.
- The medical device maker recently posted trailing-twelve-month revenue of $11.03 billion alongside earnings of $8.85 per share.
- Wall Street maintains a general buy consensus on the stock, backed by 30 analyst opinions and a mean price target of $478.53.
Get Intuitive Surgical text alerts
We text you when insiders, Congress, analysts or big funds move on $ISRG.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Intuitive Surgical, Inc. alert may contain errors. Disclosures
On October 21, 2026, Leerink Partners maintained its Outperform rating on Intuitive Surgical, Inc. (NasdaqGS: ISRG) while boosting its price target from $473.00 to $503.00. The research note outlines the firm's forward-looking view on the medical equipment maker as shares closed at $430.46 on the day of the announcement. Stock exchange data shows the company recently traded around $427.48.
ISRG
Intuitive Surgical, Inc.
Leerink Partners vs. the S&P 500
Hypothetical returns from Leerink Partners's disclosed trades, not real profit or advice. How we model this.
Leerink Partners' Call on Intuitive Surgical
In its October 21, 2026 research note, Leerink Partners kept an Outperform rating on Intuitive Surgical, Inc. and raised its target from $473.00 to $503.00. The firm's target reflects its updated expectations for the healthcare provider.
Other Institutional Activity in Intuitive Surgical
Other large funds have adjusted their holdings in the medical device maker recently. Davenport reduced its holdings by 145,132 shares, ending with 8,095 shares valued at about $3,291,545 on October 14, 2026. Meanwhile, Assenagon Asset Management S.A. grew its stake by 558,099 shares, finishing with 1,557,940 shares worth roughly $633,505,142 on October 15, 2026.
Intuitive Surgical, Inc. Stock Up 0.3%
Intuitive Surgical, Inc. shares recently traded around $427.48, down about 0.7% from the event-day close of $430.46 on October 21, 2026. The stock sits above its 50-day moving average and below its 200-day moving average.
$ISRG price target
Intuitive Surgical, Inc. daily closes and this analyst's $503 target. Not advice.
Recent Earnings
Intuitive Surgical reported trailing-twelve-month revenue of $11,034,399,744 and earnings of $8.85 per share. The company generated a net profit margin of 28.4% and a return on equity of 17.4% over the period, supported by year-over-year revenue growth of 18.5%.
Insider Buying and Selling at Intuitive Surgical, Inc.
Company insiders have made several share dispositions recently. Officer Mark Preston Brosius disposed of 154 shares valued at $59,439 on August 21, 2026, followed by 69 shares worth $24,671 on September 9, 2026, and 48 shares worth $17,141 on September 11, 2026. Additionally, officer Fredrik Widman disposed of 1,089 shares at a price of $374.44 per share for a total value of $407,765 on September 15, 2026.
Analysts Set New Price Targets
Several other firms issued updates alongside Leerink Partners on October 21, 2026. JP Morgan maintained its Overweight rating and lifted its target to $475.00 from $450.00. Evercore ISI Group maintained an In-Line rating while lowering its target from $400.00 to $385.00. Wells Fargo maintained an Overweight rating and moved its target slightly from $487.00 to $486.00. TD Cowen reiterated a Buy rating with an unchanged target of $485.00. Overall, the stock holds a buy consensus recommendation across 30 analyst opinions.
About Intuitive Surgical
Headquartered in Sunnyvale, California, Intuitive Surgical, Inc. creates robotic systems and tools that help doctors perform minimally invasive surgeries. The company operates globally, providing medical technology designed to improve patient care access and clinical outcomes. Its flagship products support surgeons across various medical specialties.
Bottom Line
Leerink Partners joins a group of major financial institutions adjusting targets for Intuitive Surgical, Inc. Investors continue to monitor analyst updates and institutional filings as the healthcare sector evolves. No investment stance is implied by these research notes.
Related Filing Alerts
Source: Leerink Partners's rating change on $ISRG (Oct 21, 2026). Written by software, not financial advice. How we make alerts